Advancements in the Treatment of Desmoid Tumors - Episode 4

Active Surveillance in Frontline Management of Desmoid Tumors

January 15, 2024

Jonathan C. Trent, MD, PhD, Mark Agulnik, MD, Marilyn Bui, MD, PhD, Chandrajit Raut, MD

A panel of oncology experts examine the significance of employing active surveillance as a primary strategy in the treatment of desmoid tumors, providing expert insights into this approach.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: An Overview of the Landscape Surrounding Desmoid Tumors

EP. 2: Expert Perspectives on the Pathogenesis and Diagnosis of Desmoid Tumors

EP. 3: Signs and Symptoms of Desmoid Tumors and Their Impact on Quality of Life

Now Viewing

EP. 4: Active Surveillance in Frontline Management of Desmoid Tumors

EP. 5: The Evolving Role of Surgery in the Management of Desmoid Tumors

EP. 6: Treatment Strategies Using Radiotherapy or Other Locoregional Approaches in Desmoid Tumors

EP. 7: Approaches to Systemic Therapy in Desmoid Tumors: The Role of Chemotherapy

EP. 8: The Role of Supportive Care Measures in Patients with Desmoid Tumors

EP. 9: Desmoid Tumors in Women: Special Considerations for Pregnancy and Contraception

EP. 10: Targeting NOTCH Pathway Signaling with Nirogacestat

EP. 11: DeFi: Nirogacestat in Patients with Progressing Desmoid Tumors

EP. 12: Impact of Nirogacestat on Pain, Quality of Life, and Fertility in Patients with Desmoid Tumors

EP. 13: Nirogacestat's Impact on the Future Treatment of Desmoid Tumors

EP. 14: Future Perspectives on the Treatment of Desmoid Tumors